Shennona

Information and communications technology (ICT) and healthcare are two of Taiwan’s most important industries. In recent years, Compal Group has actively advanced smart healthcare solutions, working closely with local governments, long-term care institutions, and medical centers to create a more accessible and intelligent healthcare environment. To strengthen localized services, Compal established its wholly owned subsidiary SHENNONA in 2019. Leveraging the Group’s ICT expertise together with precision manufacturing and design capabilities, SHENNONA focuses on smart healthcare IoT solutions and government healthcare projects, spanning the fields of medical care, eldercare, and sports health.

SHENNONA identifies the critical needs within government-led “Healthy Aging” initiatives, prioritizing on-site engagement and customer insights. Acting as a bridge between market demands and Compal’s R&D teams, SHENNONA facilitates the practical implementation of smart healthcare technologies. Our goal is to enhance communication between healthcare professionals and end-users, empowering users to experience meaningful improvements in their health journeys through smart devices.

In addition, SHENNONA supports Compal’s subsidiaries in expanding the global reach of their smart medical products, such as:

1. Aco Healthcare Co., Ltd. — Handheld Ultrasound

2. General Life Biotechnology Co., Ltd. — BeneCheck and SANcheck Multi-Functional Blood Testing Devices

3. HippoScreen Neurotech Corp. — 8-Channel EEG Amplifier, Stress EEG Assessment System, and Brain Degeneration Risk Assessment System

At Shennona, we believe every great healthcare and wellness solution begins with listening. By placing customer needs at the center of everything we do, we not only address today’s challenges but also anticipate tomorrow’s opportunities through continuous innovation.

Collaboration is our driving force. Partnering across industries, we transform ideas into reality—delivering integrated smart healthcare solutions ranging from smart hospitals and rehabilitation devices to handheld ultrasound systems, multifunctional blood testing devices, and advanced EEG-based brain health assessment tools.

As a wholly owned subsidiary of Compal Group (annual revenue: US$37B+), Shennona is dedicated 100% to medical and wellness solutions. We combine years of device design expertise with certified practices (ISO 13485, ISO 9001, FDA registration) to ensure our products meet the highest international standards.

Design excellence is the foundation of our competitiveness. Our professional R&D team not only excels in product development but also stays at the forefront of emerging technologies, enabling our clients to launch innovative, competitive products and succeed in global markets.

At Shennona, we listen, we innovate, and we deliver health-driven solutions that truly make a difference.